Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/9/10 → 6/30/11 |
Funding
- Novo Nordisk Pharmaceuticals Inc: $3,525.00
A 26-week, Randomised, Controlled, Open Label, Multicentre, Multinational Three-arm Parallel, Treat-to-Target Trial Comparing Efficacy and Safety of 2 Different Dosing Regiments of SIBA and 1 Dosing Regimen of Insulin
- Karounos, Dennis (PI)